Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

CCX Operating Software , Version 4.08

FDA Recall Z-0578-06 · Posted 2006-02-28

Recalling FirmNova Biomedical Corporation
Recall StatusTerminated
Product CodeCHL
Date Initiated2006-01-27
Date Terminated2006-10-19
Product Quantity33 units

Reason for Recall

Analyzers may fail to perform scheduled automatic two-point calibrations and Quality Control runs

Firm Action

Nova Biomedical Issued on 1/27/2006 an Advisory Notice to Stat Profile CCX Customers to report the malfunction and request the Good Laboratory Practices (GLP) be used and review be made to assure the calibration status and QC is being performed. A new software version is scheduled to be released to correct the error.

Root Cause

Other

Distribution Pattern

Nationwide Foreign: Canada, UAE, Taiwan, Singapore, Budapest, UK, France, Malaysia, France, Mexico, Korea, Finland, Germany, Turkey, Ireland, Italy, Austria, Australia, Netherlands, Venezuela, Japan, Greece, Thailand, Israel, Spain, China, Hong Kong, Argentina, Czech Republic, Croatia,Trinidad WI

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑